33 related articles for article (PubMed ID: 3132901)
1. Abnormalities in host defense associated with HIV infection.
Beck JM
Clin Chest Med; 2013 Jun; 34(2):143-53. PubMed ID: 23702166
[TBL] [Abstract][Full Text] [Related]
2. Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production.
Mikovits JA; Young HA; Vertino P; Issa JP; Pitha PM; Turcoski-Corrales S; Taub DD; Petrow CL; Baylin SB; Ruscetti FW
Mol Cell Biol; 1998 Sep; 18(9):5166-77. PubMed ID: 9710601
[TBL] [Abstract][Full Text] [Related]
3. Tuberculosis and HIV infection: a review.
Schürmann D; Nightingale SD; Bergmann F; Ruf B
Infection; 1997; 25(5):274-80. PubMed ID: 9334861
[No Abstract] [Full Text] [Related]
4. Immune dysregulation and CD4+ T cell loss in HIV-1 infection.
Meyaard L; Miedema F
Springer Semin Immunopathol; 1997; 18(3):285-303. PubMed ID: 9089950
[No Abstract] [Full Text] [Related]
5. HIV as a surrogate marker for drug use: a re-analysis of the San Francisco Men's Health Study.
Ellison BJ; Downey AB; Duesberg PH
Genetica; 1995; 95(1-3):165-71. PubMed ID: 7744259
[TBL] [Abstract][Full Text] [Related]
6. Semen alloantigens and lymphocytotoxic antibodies in AIDS and ICL.
Root-Bernstein RS; DeWitt SH
Genetica; 1995; 95(1-3):133-56. PubMed ID: 7744257
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of natural killer cell activity in human immunodeficiency virus-infected subjects by in vitro treatment with biologic response modifier OK-432.
Huang XL; Fan Z; Murayama T; Rinaldo C
Clin Diagn Lab Immunol; 1995 Jan; 2(1):91-7. PubMed ID: 7719919
[TBL] [Abstract][Full Text] [Related]
8. Selective decrease in human immunodeficiency virus type 1 (HIV-1)-induced alpha interferon production by peripheral blood mononuclear cells during HIV-1 infection.
Ferbas J; Navratil J; Logar A; Rinaldo C
Clin Diagn Lab Immunol; 1995 Mar; 2(2):138-42. PubMed ID: 7697520
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous release of interferon as a predictor of clinical evolution in HIV-positive subjects.
Biglino A; Surbone A; Lipani F; Cappello N; Forno B; Pollono AM; Busso M; Pugliese A
Infection; 1991; 19(1):7-12. PubMed ID: 2013514
[TBL] [Abstract][Full Text] [Related]
10. Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men.
van Noesel CJ; Gruters RA; Terpstra FG; Schellekens PT; van Lier RA; Miedema F
J Clin Invest; 1990 Jul; 86(1):293-9. PubMed ID: 1694865
[TBL] [Abstract][Full Text] [Related]
11. Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon.
Beck JM; Liggitt HD; Brunette EN; Fuchs HJ; Shellito JE; Debs RJ
Infect Immun; 1991 Nov; 59(11):3859-62. PubMed ID: 1682252
[TBL] [Abstract][Full Text] [Related]
12. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
13. AIDS and lymphadenopathy syndrome (LAS) patients display similar abnormal in vitro proliferation and differentiation of T-colony forming cells (T-CFC).
Lunardi Iskandar Y; Georgoulias V; Rozenbaum W; Vittecoq D; Meyer P; Gentilini M; Jasmin C
Cancer Detect Prev Suppl; 1987; 1():525-33. PubMed ID: 3500783
[TBL] [Abstract][Full Text] [Related]
14. AIDS, Kaposi sarcoma, and the lymphatic system: update and reflections.
Witte MH; Witte CL; Way DL; Fiala M
Lymphology; 1990 Jun; 23(2):73-80. PubMed ID: 2214866
[TBL] [Abstract][Full Text] [Related]
15. Interferon in AIDS.
Krown SE; Real FX; Vadhan-Raj S; Oettgen HF
J Exp Pathol; 1987; 3(4):681-91. PubMed ID: 2457669
[TBL] [Abstract][Full Text] [Related]
16. T4+ cell production of interferon gamma and the clinical spectrum of patients at risk for and with acquired immunodeficiency syndrome.
Murray HW; Scavuzzo DA; Kelly CD; Rubin BY; Roberts RB
Arch Intern Med; 1988 Jul; 148(7):1613-6. PubMed ID: 3132901
[TBL] [Abstract][Full Text] [Related]
17. Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production.
Murray HW; Hillman JK; Rubin BY; Kelly CD; Jacobs JL; Tyler LW; Donelly DM; Carriero SM; Godbold JH; Roberts RB
N Engl J Med; 1985 Dec; 313(24):1504-10. PubMed ID: 3934537
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
